Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 69

1.

A multicentre, double blind, randomised, placebo controlled trial of anakinra (Kineret), a recombinant interleukin 1 receptor antagonist, in patients with rheumatoid arthritis treated with background methotrexate.

Cohen SB, Moreland LW, Cush JJ, Greenwald MW, Block S, Shergy WJ, Hanrahan PS, Kraishi MM, Patel A, Sun G, Bear MB; 990145 Study Group..

Ann Rheum Dis. 2004 Sep;63(9):1062-8. Epub 2004 Apr 13.

2.
3.

Infliximab and methotrexate in the treatment of rheumatoid arthritis: a systematic review and meta-analysis of dosage regimens.

Zintzaras E, Dahabreh IJ, Giannouli S, Voulgarelis M, Moutsopoulos HM.

Clin Ther. 2008 Nov;30(11):1939-55. doi: 10.1016/j.clinthera.2008.11.007. Review.

PMID:
19108784
4.
5.

Addressing the safety of anakinra in patients with rheumatoid arthritis.

Fleischmann RM.

Rheumatology (Oxford). 2003 May;42 Suppl 2:ii29-35. Review.

PMID:
12817093
6.

[IL-1Ra (recombinant human IL-1 receptor antagonist) in the treatment of rheumatoid arthritis: the efficacy].

Fiocco U, Vezzù M, Cozzi L, Todesco S.

Reumatismo. 2004 Jan-Mar;56(1 Suppl 1):62-73. Review. Italian.

7.

Anakinra: a review of its use in the management of rheumatoid arthritis.

Waugh J, Perry CM.

BioDrugs. 2005;19(3):189-202. Review.

PMID:
15984903
8.

Anakinra: an inhibitor of IL-1 for the treatment of rheumatoid arthritis.

Fleischmann R, Stern R, Iqbal I.

Expert Opin Biol Ther. 2004 Aug;4(8):1333-44. Review.

PMID:
15268666
9.

[Treatment of rheumatoid arthritis with anakinra, a recombinant human interleukin-1 receptor antagonist].

Suzuki T.

Nihon Rinsho. 2002 Dec;60(12):2397-400. Review. Japanese.

PMID:
12510368
10.

[Interleukin-1 receptor antagonist anakinra (Kineret) for treatment of rheumatic arthritis].

Rubbert-Roth A, Perniok A.

Z Rheumatol. 2003 Aug;62(4):367-77. Review. German.

PMID:
12928941
11.

Anakinra for rheumatoid arthritis: a systematic review.

Mertens M, Singh JA.

J Rheumatol. 2009 Jun;36(6):1118-25. doi: 10.3899/jrheum.090074. Epub 2009 May 15. Review.

PMID:
19447938
12.

Bringing the clinical experience with anakinra to the patient.

Cohen SB, Rubbert A.

Rheumatology (Oxford). 2003 May;42 Suppl 2:ii36-40. Review.

PMID:
12817094
13.
14.

[Interleukin-1 receptor antagonists in the treatment rheumatoid arthritis].

Zoń-Giebel A, Kotulska A, Giebel S, Cader SA, Kucharz EJ.

Przegl Lek. 2002;59(11):916-8. Review. Polish.

PMID:
12715722
15.

Anakinra for rheumatoid arthritis.

Mertens M, Singh JA.

Cochrane Database Syst Rev. 2009 Jan 21;(1):CD005121. doi: 10.1002/14651858.CD005121.pub3. Review.

PMID:
19160248
16.

[Anakinra for therapy of rheumatoid arthritis].

Tomoo T, Sumida T.

Nihon Rinsho. 2005 Jan;63 Suppl 1:534-7. Review. Japanese. No abstract available.

PMID:
15799413
17.

Examining the efficacy of biologic therapy: are there real differences?

Fleischmann RM.

J Rheumatol Suppl. 2002 Sep;65:27-32. Review.

PMID:
12236619
18.

Treatment with infliximab plus methotrexate improves anemia in patients with rheumatoid arthritis independent of improvement in other clinical outcome measures-a pooled analysis from three large, multicenter, double-blind, randomized clinical trials.

Doyle MK, Rahman MU, Han C, Han J, Giles J, Bingham CO 3rd, Bathon J.

Semin Arthritis Rheum. 2009 Oct;39(2):123-31. doi: 10.1016/j.semarthrit.2008.08.002. Epub 2008 Sep 27. Review.

PMID:
18823645
19.

The use of anakinra, an interleukin-1 receptor antagonist, in the treatment of rheumatoid arthritis.

Cohen SB.

Rheum Dis Clin North Am. 2004 May;30(2):365-80, vii. Review.

PMID:
15172046
20.

Potential therapeutic uses of interleukin 1 receptor antagonists in human diseases.

Hallegua DS, Weisman MH.

Ann Rheum Dis. 2002 Nov;61(11):960-7. Review.

Supplemental Content

Support Center